본문으로 건너뛰기
← 뒤로

Successful Treatment of Peripheral T-cell Lymphoma Not Otherwise Specified in Bilateral Subconjunctiva: A Case Report.

증례보고 1/5 보강
Cureus 📖 저널 OA 99.9% 2021: 42/43 OA 2022: 79/79 OA 2023: 181/181 OA 2024: 284/284 OA 2025: 774/774 OA 2026: 506/506 OA 2021~2026 2025 Vol.17(12) p. e100285
Retraction 확인
출처

Ota H, Arihiro K, Mihara K, Chikama TI

📝 환자 설명용 한 줄

Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) typically presents in lymph nodes with advanced-stage disease.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Ota H, Arihiro K, et al. (2025). Successful Treatment of Peripheral T-cell Lymphoma Not Otherwise Specified in Bilateral Subconjunctiva: A Case Report.. Cureus, 17(12), e100285. https://doi.org/10.7759/cureus.100285
MLA Ota H, et al.. "Successful Treatment of Peripheral T-cell Lymphoma Not Otherwise Specified in Bilateral Subconjunctiva: A Case Report.." Cureus, vol. 17, no. 12, 2025, pp. e100285.
PMID 41613700 ↗

Abstract

Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) typically presents in lymph nodes with advanced-stage disease. Ocular adnexal involvement, particularly bilateral subconjunctival presentation, is exceptionally rare. We describe a 39-year-old woman who presented with progressive bilateral conjunctival masses despite one year of topical corticosteroid treatment. Examination revealed well-demarcated pink subconjunctival nodules in both eyes. Following surgical excision, histopathological and immunophenotypic analyses confirmed PTCL-NOS with CD3+/CD4+ T-cell infiltration. Molecular studies detected clonal T-cell receptor gene rearrangement in both tumor tissue and bone marrow, indicating stage II disease. The patient achieved complete remission with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy and remains disease-free after three years. To our knowledge, this represents the first reported case of primary bilateral subconjunctival PTCL-NOS successfully managed with systemic chemotherapy, highlighting the importance of comprehensive evaluation and aggressive treatment in this unusual presentation.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (2)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기